Literature DB >> 26546668

Validating hospital antibiotic purchasing data as a metric of inpatient antibiotic use.

Charlie Tan1, Michael Ritchie2, Jason Alldred3, Nick Daneman4.   

Abstract

OBJECTIVES: Antibiotic purchasing data are a widely used, but unsubstantiated, measure of antibiotic consumption. To validate this source, we compared purchasing data from hospitals and external medical databases with patient-level dispensing data.
METHODS: Antibiotic purchasing and dispensing data from internal hospital records and purchasing data from IMS Health were obtained for two hospitals between May 2013 and April 2015. Internal purchasing data were validated against dispensing data, and IMS data were compared with both internal metrics. Scatterplots of individual antimicrobial data points were generated; Pearson's correlation and linear regression coefficients were computed. A secondary analysis re-examined these correlations over shorter calendar periods.
RESULTS: Internal purchasing data were strongly correlated with dispensing data, with correlation coefficients of 0.90 (95% CI = 0.83-0.95) and 0.98 (95% CI = 0.95-0.99) at hospitals A and B, respectively. Although dispensing data were consistently lower than purchasing data, this was attributed to a single antibiotic at both hospitals. IMS data were favourably correlated with, but underestimated, internal purchasing and dispensing data. This difference was accounted for by eight antibiotics for which direct sales from some manufacturers were not included in the IMS database. The correlation between purchasing and dispensing data was consistent across periods as short as 3 months, but not at monthly intervals.
CONCLUSIONS: Both internal and external antibiotic purchasing data are strongly correlated with dispensing data. If outliers are accounted for appropriately, internal purchasing data could be used for cost-effective evaluation of antimicrobial stewardship programmes, and external data sets could be used for surveillance and research across geographical regions.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26546668      PMCID: PMC4710217          DOI: 10.1093/jac/dkv373

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.

Authors:  Patricia L Schirmer; Renee C Mercier; Russell A Ryono; Nancy Nguyen; Cynthia A Lucero; Gina Oda; Mark Holodniy
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04       Impact factor: 3.254

2.  Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors.

Authors:  David M Livermore; Rosy Reynolds; Peter Stephens; Georgia Duckworth; David Felmingham; Alan P Johnson; Stephen Murchan; Olive Murphy; Usha Gungabissoon; Pauline Waight; Richard Pebody; Jemma Shackcloth; Marina Warner; Laura Williams; Robert C George
Journal:  Int J Antimicrob Agents       Date:  2006-09-14       Impact factor: 5.283

3.  Antibiotic resistance in long-term acute care hospitals: the perfect storm.

Authors:  Carolyn V Gould; Richard Rothenberg; James P Steinberg
Journal:  Infect Control Hosp Epidemiol       Date:  2006-08-21       Impact factor: 3.254

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Antimicrobial consumption data from pharmacy and nursing records: how good are they?

Authors:  Gail S Itokazu; Robert C Glowacki; David N Schwartz; Mary F Wisniewski; Robert J Rydman; Robert A Weinstein
Journal:  Infect Control Hosp Epidemiol       Date:  2005-04       Impact factor: 3.254

6.  Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.

Authors:  Conan MacDougall; J Patrick Powell; Christopher K Johnson; Michael B Edmond; Ronald E Polk
Journal:  Clin Infect Dis       Date:  2005-06-28       Impact factor: 9.079

7.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

8.  Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals.

Authors:  Jon B Haug; Randi Myhr; Asmund Reikvam
Journal:  BMC Med Res Methodol       Date:  2011-12-13       Impact factor: 4.615

Review 9.  Antimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact.

Authors:  Andrew M Morris
Journal:  Curr Treat Options Infect Dis       Date:  2014

10.  Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe.

Authors:  Ann Versporten; Ganna Bolokhovets; Lilit Ghazaryan; Vafa Abilova; Galina Pyshnik; Tijana Spasojevic; Irma Korinteli; Lul Raka; Baktygul Kambaralieva; Lidija Cizmovic; Angela Carp; Vesela Radonjic; Nargis Maqsudova; Hatice Demet Celik; Marina Payerl-Pal; Hanne Bak Pedersen; Nina Sautenkova; Herman Goossens
Journal:  Lancet Infect Dis       Date:  2014-03-20       Impact factor: 25.071

View more
  4 in total

1.  Regional variability in outpatient antibiotic use in Ontario, Canada: a retrospective cross-sectional study.

Authors:  Kevin L Schwartz; Camille Achonu; Kevin Antoine Brown; Bradley Langford; Nick Daneman; Jennie Johnstone; Gary Garber
Journal:  CMAJ Open       Date:  2018-10-31

2.  Validating a popular outpatient antibiotic database to reliably identify high prescribing physicians for patients 65 years of age and older.

Authors:  Kevin L Schwartz; Cynthia Chen; Bradley J Langford; Kevin A Brown; Nick Daneman; Jennie Johnstone; Julie Hc Wu; Valerie Leung; Gary Garber
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

3.  The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis.

Authors:  Charlotte G Boone; Tony Antoniou; David N Juurlink; Teagan Rolf von den Baumen; Sophie A Kitchen; Georgia C Richards; Mina Tadrous; Tara Gomes
Journal:  CMAJ Open       Date:  2021-12-14

4.  Interprovincial variation in antibiotic use in Canada, 2019: a retrospective cross-sectional study.

Authors:  Michael Crosby; Teagan Rolf von den Baumen; Cherry Chu; Tara Gomes; Kevin L Schwartz; Mina Tadrous
Journal:  CMAJ Open       Date:  2022-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.